CAS, Molecule.one team up to transform chemical synthesis planning for drug discovery
As part of the efforts to improve their solutions, CAS will integrate Molecule.one's deep learning models for better…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
14 Aug 23
As part of the efforts to improve their solutions, CAS will integrate Molecule.one's deep learning models for better…
14 Aug 23
As part of the collaboration, Logomix will initially contribute genome editing capabilities to assist HebeCell in creating the…
14 Aug 23
The launched ABSORBABLE supplements range includes three proprietary combinations of Vitamin C, Vitamin D3 1000 IU, and Vitamin…
14 Aug 23
ZM008 is a human IgG1 monoclonal antibody against LLT1 (CLEC2D), which disrupts the interaction of LLT1-CD161 between human…
14 Aug 23
Acquisition of Chinook Therapeutics, a clinical-stage biopharmaceutical company, completed for $3.2bn upfront
11 Aug 23
Inversago’s lead asset, INV-202, specifically blocks the receptor protein CB1, which plays key role in metabolism and appetite…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
11 Aug 23
The FDA approval was based on results from the talquetamab Phase 2 MonumenTAL-1 study in which Talvey showed…
11 Aug 23
The investment will help Astellas to establish a significant presence in life science innovation hotspots in the world…
11 Aug 23
Under the partnership, Lotus will oversee obtaining regulatory approval and will have the sole right to market Adlarity…
11 Aug 23
Under the agreement, Antengene will retain its responsibilities for R&D, regulatory approvals and affairs, product supply, and distribution…